Analystreport

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Piper Sandler from $4.00 to $3.00.

Leap Therapeutics, Inc.  (LPTX) 
Last leap therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.leaptx.com